Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Apr-21 7:55 PM View:  | Freedman Edward D. Chief Operating Officer | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 54,460 | $60.00 | $3,267,600.00 | (100%) 54.46K to 0 | (< 1%) |
| 01-Apr-21 7:50 PM View: | Kakkar Rahul Chief Executive Officer Director | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 702,515 | $60.00 | $42,150,900.00 | (100%) 702.51K to 0 | (< 1%) |
| 01-Apr-21 7:59 PM View: | Viney Joanne L. See Remarks | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 1,200 | $60.00 | $72,000.00 | (100%) 1.2K to 0 | (< 1%) |
| 01-Apr-21 7:45 PM View: | Frail Donald Director | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 61,113 | $60.00 | $3,666,780.00 | (100%) 61.11K to 0 | (< 1%) |
| 01-Apr-21 7:49 PM View: | Becker Daniel J. Director | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 2,827,880 | $60.00 | $169,672,992.00 | (100%) 2.83M to 0 | (< 1%) |
| 01-Apr-21 7:57 PM View: | Crane Alan L Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 3,537,740 | $60.00 | $212,264,000.00 | (100%) 3.54M to 0 | (< 1%) |
| 01-Apr-21 7:49 PM View: | Fuglesang Christopher Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 2,131,140 | $60.00 | $127,868,000.00 | (100%) 2.13M to 0 | (< 1%) |
| 01-Apr-21 7:58 PM View: | Goyal Vikas See Remarks | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 87,764 | $60.00 | $5,265,840.00 | (100%) 87.76K to 0 | (< 1%) |
| 01-Apr-21 7:46 PM View: | Sundy John Chief Medical Officer | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 115,826 | $60.00 | $6,949,560.00 | (100%) 115.83K to 0 | (< 1%) |
| 01-Apr-21 7:43 PM View: | Carroll Jill Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 5,674,220 | $60.00 | $340,452,992.00 | (100%) 5.67M to 0 | (< 1%) |
| 01-Apr-21 7:46 PM View: | Stagliano Nancy Director | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 1,000 | $60.00 | $60,000.00 | (1%) 74.07K to 73.07K | (< 1%) |
| 01-Apr-21 7:50 PM View: | Kakkar Rahul Chief Executive Officer Director | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 14,000 | $60.00 | $840,000.00 | (2%) 716.51K to 702.51K | (< 1%) |
| 01-Apr-21 7:37 PM View: | Larson Eric D Vice President, Finance | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 22,125 | $60.00 | $1,327,500.00 | (100%) 22.13K to 0 | (< 1%) |
| 01-Apr-21 7:59 PM View: | Viney Joanne L. See Remarks | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 503,254 | $60.00 | $30,195,200.00 | (100%) 504.45K to 1.2K | (< 1%) |
| 01-Apr-21 7:53 PM View: | Beloff Gregg See Remarks | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 13,196 | $60.00 | $791,760.00 | (100%) 13.2K to 0 | (< 1%) |
| 01-Apr-21 7:49 PM View: | Becker Daniel J. Director | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 1,000 | $60.00 | $60,000.00 | (< 1%) 2.83M to 2.83M | (< 1%) |
| 01-Apr-21 7:46 PM View: | Stagliano Nancy Director | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 73,067 | $60.00 | $4,384,020.00 | (100%) 73.07K to 0 | (< 1%) |
| 01-Apr-21 7:57 PM View: | Crane Alan L Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 84,158 | $60.00 | $5,049,480.00 | (2%) 3.62M to 3.54M | (< 1%) |
| 23-Nov-20 5:30 PM View: | Becker Daniel J. Director | Pandion Therapeutics, Inc. (PAND) | 19-Nov-20 | Purchase | 197,716 | $15.12 | $2,989,470.00 | 8% 2.63M to 2.83M | |
| 19-Nov-20 8:15 PM View: | Becker Daniel J. Director | Pandion Therapeutics, Inc. (PAND) | 18-Nov-20 | Purchase | 14,197 | $15.26 | $216,646.00 | < 1% 2.62M to 2.63M | |
| 19-Nov-20 8:15 PM View: | Becker Daniel J. Director | Pandion Therapeutics, Inc. (PAND) | 17-Nov-20 | Purchase | 15,197 | $15.32 | $232,754.00 | < 1% 2.6M to 2.62M | |
| 21-Jul-20 7:39 PM View: | Becker Daniel J. Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 1,000 | $18.00 | $18,000.00 | < 1% 2.6M to 2.6M | |
| 21-Jul-20 7:51 PM View: | Polaris Partners Gp Viii, L... 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion Duplicate | 3,165,310 | -- | -- | 100% 0 to 3.17M | |
| 21-Jul-20 7:32 PM View: | Viney Joanne L. See Remarks | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 21,133 | -- | -- | 4% 482.12K to 503.25K | |
| 21-Jul-20 7:41 PM View: | Versant Venture Capital Vi,... 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 577,544 | -- | -- | 18% 3.18M to 3.75M | |
| 22-Jul-20 4:18 PM View: | Glaxosmithkline Plc Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion Duplicate | 1,887,190 | -- | -- | 100% 0 to 1.89M | |
| 21-Jul-20 7:39 PM View: | Goyal Vikas See Remarks | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 1,450 | $18.00 | $26,100.00 | 2% 86.31K to 87.76K | |
| 21-Jul-20 7:33 PM View: | Sundy John Chief Medical Officer | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 2,000 | $18.00 | $36,000.00 | 2% 113.83K to 115.83K | |
| 21-Jul-20 7:47 PM View: | Carroll Jill Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 361,111 | $18.00 | $6,500,000.00 | 19% 1.89M to 2.25M | |
| 21-Jul-20 7:33 PM View: | Stagliano Nancy Director | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 1,000 | $18.00 | $18,000.00 | 1% 73.07K to 74.07K | |
| 21-Jul-20 7:44 PM View: | Crane Alan L Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 36,111 | $18.00 | $649,998.00 | 1% 3.57M to 3.61M | |
| 23-Jul-20 4:49 PM View: | Mutz Mitchell Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 3,049,970 | -- | -- | 100% 0 to 3.05M | |
| 21-Jul-20 7:49 PM View: | Boxer Capital, LLC 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 23,622 | -- | -- | 2% 1.39M to 1.41M | |
| 21-Jul-20 7:35 PM View: | Kakkar Rahul Chief Executive Officer Director | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 14,000 | $18.00 | $252,000.00 | 2% 702.51K to 716.51K | |
| 21-Jul-20 7:39 PM View: | Becker Daniel J. Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 1,878,550 | -- | -- | 100% 0 to 1.88M | |
| 23-Jul-20 4:50 PM View: | Roche Holding Ltd 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion Duplicate | 3,049,970 | -- | -- | 100% 0 to 3.05M | |
| 21-Jul-20 7:28 PM View: | Larson Eric D Vice President, Finance | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 600 | $18.00 | $10,800.00 | 3% 21.52K to 22.13K | |
| 21-Jul-20 7:51 PM View: | Polaris Partners Gp Viii, L... 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase Duplicate | 36,111 | $18.00 | $649,998.00 | 1% 3.17M to 3.2M | |
| 21-Jul-20 7:32 PM View: | Viney Joanne L. See Remarks | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 1,200 | $18.00 | $21,600.00 | < 1% 503.25K to 504.45K | |
| 22-Jul-20 4:30 PM View: | Ra Capital Management, LLC 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 1,408,910 | -- | -- | 100% 0 to 1.41M | |
| 21-Jul-20 7:29 PM View: | Frail Donald Director | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 11,741 | -- | -- | 30% 39.37K to 51.11K | |
| 22-Jul-20 4:18 PM View: | Glaxosmithkline Plc Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase Duplicate | 361,111 | $18.00 | $6,500,000.00 | 19% 1.89M to 2.25M | |
| 21-Jul-20 7:45 PM View: | Jdrf T1d Fund LLC 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 426,333 | -- | -- | 100% 0 to 426.33K | |
| 21-Jul-20 7:44 PM View: | Crane Alan L Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 3,165,310 | -- | -- | 821% 385.34K to 3.55M | |
| 21-Jul-20 7:44 PM View: | Crane Alan L Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 14,000 | $18.00 | $252,000.00 | < 1% 3.61M to 3.62M | |
| 23-Jul-20 4:49 PM View: | Mutz Mitchell Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 46,111 | $18.00 | $829,998.00 | 2% 3.05M to 3.1M | |
| 21-Jul-20 7:49 PM View: | Boxer Capital, LLC 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 722,222 | $18.00 | $13,000,000.00 | 51% 1.41M to 2.13M | |
| 21-Jul-20 7:44 PM View: | Fuglesang Christopher Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 1,408,910 | -- | -- | 75% 1.88M to 3.29M | |
| 21-Jul-20 7:28 PM View: | Freedman Edward D. Chief Operating Officer | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 2,348 | -- | -- | 5% 52.11K to 54.46K | |
| 21-Jul-20 7:39 PM View: | Becker Daniel J. Director 10% Owner | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase Duplicate | 722,222 | $18.00 | $13,000,000.00 | 38% 1.88M to 2.6M |
